Clinical Trial Update: Impact of an Increased Restrictive Factor of One Anastomosis Gastric Bypass on Metabolic Outcomes Type 2 Diabetes. [NA]

View source ↗

Summary

A completed clinical trial evaluated how increasing the restrictive factor of the One Anastomosis Gastric Bypass affects metabolic outcomes in individuals with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: The Society of Bariatric and Metabolic Surgeons of Kazakhstan | Conditions: Obesity, Morbid, Diabetes Mellitus, Type 2 | NA | Status: COMPLETED